Information  X 
Enter a valid email address
  Print      Mail a friend       More announcements

Monday 16 September, 2019

JP Morgan Sec LLC

Allergan plc 38.5b

RNS Number : 4684M
J.P. Morgan Securities LLC
16 September 2019
 

Ap27

 

FORM 38.5(b)

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DEALINGS BY CONNECTED EXEMPT PRINCIPAL TRADERS WITHOUT RECOGNISED INTERMEDIARY STATUS, OR WITH RECOGNISED INTERMEDIARY STATUS BUT NOT DEALING IN A CLIENT-SERVING CAPACITY

 

 

1.          KEY INFORMATION

 

Name of exempt principal trader

J.P. Morgan Securities LLC

Company dealt in

Allergan plc

Class of relevant security to which the dealings being disclosed relate (Note 1)

$0.0001 ordinary shares

Date of dealing

13 September 2019

 

2.          INTERESTS AND SHORT POSITIONS

 

(a)         Interests and short positions (following dealing) in the class of relevant security dealt in (Note 2)

 

 

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

5,070,215 (1.54%)

1,038,359 (0.32%)

(2) Derivatives (other than options)

904,931 (0.28%)

4,324,223 (1.32%)

(3) Options and agreements to purchase/sell

1,350,139 (0.41%)

1,073,039 (0.33%)

Total

7,325,286 (2.23%)

6,435,621 (1.97%)

 

 

(b)         Interests and short positions in relevant securities of the company, other than the class dealt in (Note 2)

 

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

-

-

(2) Derivatives (other than options)

-

-

(3) Options and agreements to purchase/sell

-

-

Total

-

-

 

 

 

Ap28

 

 

3.       DEALINGS (Note 3)

 

(a)      Purchases and sales

 

 

Purchases/ sales

 

Number of relevant securities

Price per unit  (USD)

Purchases

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Sales

10

16

1,575

690

65

6,754

3,908

202

385

3,344

795

357

300

407

405

1,864

177

400

100

2,648

2,789

10

481

123

2,845

140

2,322

2,033

415

136

252

4,534

2,198

130

407

3,029

186

1

100

656

100

1,696

577

115

1,939

317

257

100

97

130

206

 

239

200

100

4,731

2,700

100

4

1

5

99

3,300

9

400

1

7

206

100

165.7100

165.7350

165.7571

165.7598

165.7600

165.7605

165.7655

165.7666

165.7708

165.7712

165.7718

165.7734

165.8200

165.8300

165.8950

165.9310

165.9430

166.0275

166.0966

166.1400

166.1471

166.2200

166.2342

166.2600

166.2607

166.2654

166.2820

166.2856

166.2927

166.2954

166.3000

166.3037

166.3251

166.3300

166.3313

166.3352

166.3400

166.3500

166.3600

166.3929

166.3950

166.4042

166.4105

166.4200

166.4270

166.4452

166.4857

166.4900

166.5000

166.5123

166.8100

 

165.7491

165.8900

165.9700

166.1400

166.1880

166.2600

166.2900

166.3500

166.4160

166.5000

166.5223

166.5700

166.5900

166.7000

166.7186

166.8100

166.8200

 

 

 

(b)      Derivatives transactions (other than options transactions)

 

Product name,

e.g. CFD

Nature of transaction

(Note 5)

Number of relevant securities

(Note 6)

Price per unit (USD)

(Note 4)

Equity Swaps

 

 

 

 

 

(c)      Options transactions in respect of existing relevant securities

 

 

(i)       Writing, selling, purchasing or varying

 

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

(USD)

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 4)

(USD)

 

 

 

 

 

 

 

 

 

(ii)      Exercising

 

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 4) (USD)

 

 

 

 

 

 

(d)      Other dealings (including transactions in respect of new securities) (Note 3)

 

Nature of transaction

(Note 7)

Details

Price per unit

(if applicable) (Note 4)

 

 

 

 

 

 

 

 

 

 

Ap29

 

4.       OTHER INFORMATION

 

Agreements, arrangements or understandings relating to options or derivatives

 

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities 
under any option referred to on this form or relating to the voting rights or future acquisition 
or disposal of any relevant securities to which any derivative referred to on this form is referenced. 
If none, this should be stated.

 

 

 

 

 

 

 

 

Is a Supplemental Form 38.5(b) attached? (Note 8)                    Yes

 

 

Date of disclosure

16 September 2019

Contact name

Alwyn Basch

Telephone number

020 7742 7407

Name of offeree/offeror with which connected

Allergan plc

Nature of connection (Note 9)

Financial Advisor to Allergan plc

 

Ap31

 

 

SUPPLEMENTAL FORM 38.5(b)

 

 

 

 

IRISH TAKEOVER PANEL

 

DISCLOSURE UNDER RULE 38.5(b) OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

 

DETAILS OF OPEN POSITIONS

 

(This form should be attached to Form 38.5(b)) OPEN POSITIONS (Note 1)

 

Product name,

e.g. call option

Written or purchased

Number of relevant securities to which the option or derivative relates

Exercise price (Note 2)

Type, e.g. American, European etc.

Expiry date

Call Option

Written

267,500

125.00

American

15/11/2019

Call Option

Purchased

214,500

150.00

American

15/11/2019

Call Option

Written

7,000

155.00

American

17/01/2020

Call Option

Written

5,000

210.00

American

17/01/2020

Call Option

Purchased

100,363

104.11

European

23/01/2020

Call Option

Written

100,363

104.11

European

23/01/2020

Call Option

Written

100,363

108.45

European

23/01/2020

Call Option

Purchased

100,363

108.45

European

23/01/2020

Put Option

Written

5,000

140.00

American

17/01/2020

Put Option

Written

65,100

95.00

American

17/01/2020

Put Option

Written

45,000

160.00

American

20/12/2019

Put Option

Written

300,000

150.00

American

19/06/2020

Put Option

Purchased

233,402

104.11

European

23/01/2020

Put Option

Written

233,402

104.11

European

23/01/2020

Put Option

Written

261,411

108.45

European

23/01/2020

Put Option

Purchased

261,411

108.45

European

23/01/2020

Put Option

Written

5,000

140.00

American

19/06/2020

Put Option

Purchasing

88,000

150.00

American

20/12/2019

Call Option

Purchasing

20,000

185.00

American

21/02/2020

Call Option

Written

10,000

170.00

American

21/02/2020

 

 

Notes

 

1.       Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

 

2.       For all prices and other monetary amounts, the currency must be stated.

 

For full details of disclosure requirements, see Rules 8 and

38.5 of the Rules. If in doubt, consult the Panel.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
ISEBQLFFKKFEBBX

a d v e r t i s e m e n t